186 related articles for article (PubMed ID: 19057652)
1. Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages.
Tam SP; Kisilevsky R; Ancsin JB
PLoS One; 2008; 3(12):e3867. PubMed ID: 19057652
[TBL] [Abstract][Full Text] [Related]
2. ATP binding cassette G1-dependent cholesterol efflux during inflammation.
de Beer MC; Ji A; Jahangiri A; Vaughan AM; de Beer FC; van der Westhuyzen DR; Webb NR
J Lipid Res; 2011 Feb; 52(2):345-53. PubMed ID: 21138980
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch.
Elimova E; Kisilevsky R; Ancsin JB
FASEB J; 2009 Oct; 23(10):3436-48. PubMed ID: 19549924
[TBL] [Abstract][Full Text] [Related]
4. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages.
Artl A; Marsche G; Lestavel S; Sattler W; Malle E
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):763-72. PubMed ID: 10712402
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.
Banka CL; Yuan T; de Beer MC; Kindy M; Curtiss LK; de Beer FC
J Lipid Res; 1995 May; 36(5):1058-65. PubMed ID: 7658153
[TBL] [Abstract][Full Text] [Related]
6. HDL remodeling during the acute phase response.
Jahangiri A; de Beer MC; Noffsinger V; Tannock LR; Ramaiah C; Webb NR; van der Westhuyzen DR; de Beer FC
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):261-7. PubMed ID: 19008529
[TBL] [Abstract][Full Text] [Related]
7. Acute-phase serum amyloid A: perspectives on its physiological and pathological roles.
Kisilevsky R; Manley PN
Amyloid; 2012 Mar; 19(1):5-14. PubMed ID: 22320226
[TBL] [Abstract][Full Text] [Related]
8. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.
Marsche G; Frank S; Raynes JG; Kozarsky KF; Sattler W; Malle E
Biochem J; 2007 Feb; 402(1):117-24. PubMed ID: 17034364
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I.
van der Westhuyzen DR; Cai L; de Beer MC; de Beer FC
J Biol Chem; 2005 Oct; 280(43):35890-5. PubMed ID: 16120612
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e.
Paka L; Kako Y; Obunike JC; Pillarisetti S
J Biol Chem; 1999 Feb; 274(8):4816-23. PubMed ID: 9988721
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function.
Kisilevsky R; Subrahmanyan L
Lab Invest; 1992 Jun; 66(6):778-85. PubMed ID: 1602745
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.
Lorenzi I; von Eckardstein A; Cavelier C; Radosavljevic S; Rohrer L
J Mol Med (Berl); 2008 Feb; 86(2):171-83. PubMed ID: 17906976
[TBL] [Abstract][Full Text] [Related]
13. Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
Murakami H; Tanabe J; Tamasawa N; Matsumura K; Yamashita M; Matsuki K; Murakami H; Matsui J; Suda T
Diabetes Res Clin Pract; 2013 Jan; 99(1):30-8. PubMed ID: 23137417
[TBL] [Abstract][Full Text] [Related]
14. Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion.
Pussinen PJ; Malle E; Metso J; Sattler W; Raynes JG; Jauhiainen M
Atherosclerosis; 2001 Apr; 155(2):297-305. PubMed ID: 11254899
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells.
Nguyen SD; Öörni K; Lee-Rueckert M; Pihlajamaa T; Metso J; Jauhiainen M; Kovanen PT
J Lipid Res; 2012 Oct; 53(10):2115-2125. PubMed ID: 22855736
[TBL] [Abstract][Full Text] [Related]
16. HDL cholesterol transport during inflammation.
van der Westhuyzen DR; de Beer FC; Webb NR
Curr Opin Lipidol; 2007 Apr; 18(2):147-51. PubMed ID: 17353662
[TBL] [Abstract][Full Text] [Related]
17. Heparin interactions with apoA1 and SAA in inflammation-associated HDL.
Digre A; Nan J; Frank M; Li JP
Biochem Biophys Res Commun; 2016 May; 474(2):309-314. PubMed ID: 27105909
[TBL] [Abstract][Full Text] [Related]
18. New insights into the regulation of HDL metabolism and reverse cholesterol transport.
Lewis GF; Rader DJ
Circ Res; 2005 Jun; 96(12):1221-32. PubMed ID: 15976321
[TBL] [Abstract][Full Text] [Related]
19. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse.
Lindhorst E; Young D; Bagshaw W; Hyland M; Kisilevsky R
Biochim Biophys Acta; 1997 Apr; 1339(1):143-54. PubMed ID: 9165109
[TBL] [Abstract][Full Text] [Related]
20. Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism.
Schmitz G; Robenek H; Beuck M; Krause R; Schurek A; Niemann R
Arteriosclerosis; 1988; 8(1):46-56. PubMed ID: 2829803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
